TY - JOUR
T1 - Biallelic ZNFX1 variants are associated with a spectrum of immuno-hematological abnormalities
AU - Alawbathani, Salem
AU - Westenberger, Ana
AU - Ordonez-Herrera, Natalia
AU - Al-Hilali, Mariam
AU - Al Hebby, Homoud
AU - Alabbas, Fahad
AU - Alhashem, Amal M.
AU - Elyamany, Ghaleb
AU - Megarbane, André
AU - Kose, Melis
AU - Alhashmi, Nadia
AU - Al Sukaiti, Nashat
AU - Al-Raqad, Mohammed
AU - Al-Tawalbeh, Samah
AU - Abu Adas Blanco, Omar
AU - Alkhattabi, Fadiah
AU - Sng, Danielle
AU - Al-Ali, Ruslan
AU - Khan, Suliman
AU - Tawamie, Hasan
AU - Tripolszki, Kornelia
AU - Karageorgou, Vasiliki
AU - Trunzo, Roberta
AU - Al Mutairi, Fuad
AU - Reversade, Bruno
AU - Bauer, Peter
AU - Bertoli-Avella, Aida M.
N1 - Generated from Scopus record by KAUST IRTS on 2023-02-15
PY - 2022/2/1
Y1 - 2022/2/1
N2 - Biallelic changes in the ZNFX1 gene have been recently reported to cause severe familial immunodeficiency. Through a search of our bio/databank with information from genetic testing of >55 000 individuals, we identified nine additional patients from seven families with six novel homozygous ZNFX1 variants. Consistent with the previously described phenotype, our patients suffered from monocytosis, thrombocytopenia, hepatosplenomegaly, recurrent infections, and lymphadenopathy. The two most severely affected probands also had renal involvement and clinical presentations compatible with hemophagocytic lymphohistiocytosis. The disease was less lethal among our patients than previously reported. We identified two missense changes, two variants predicted to result in complete protein loss through nonsense-mediated decay, and two frameshift changes that likely introduce a truncation. Our findings (i) independently confirm the role of ZNFX1 in primary genetic immunodeficiency, (ii) expand the genetic and clinical spectrum of ZNFX1-related disease, and (iii) illustrate the utility of large, well-curated, and continually updated genotype–phenotype databases in resolving molecular diagnoses of patients with initially negative genetic testing findings.
AB - Biallelic changes in the ZNFX1 gene have been recently reported to cause severe familial immunodeficiency. Through a search of our bio/databank with information from genetic testing of >55 000 individuals, we identified nine additional patients from seven families with six novel homozygous ZNFX1 variants. Consistent with the previously described phenotype, our patients suffered from monocytosis, thrombocytopenia, hepatosplenomegaly, recurrent infections, and lymphadenopathy. The two most severely affected probands also had renal involvement and clinical presentations compatible with hemophagocytic lymphohistiocytosis. The disease was less lethal among our patients than previously reported. We identified two missense changes, two variants predicted to result in complete protein loss through nonsense-mediated decay, and two frameshift changes that likely introduce a truncation. Our findings (i) independently confirm the role of ZNFX1 in primary genetic immunodeficiency, (ii) expand the genetic and clinical spectrum of ZNFX1-related disease, and (iii) illustrate the utility of large, well-curated, and continually updated genotype–phenotype databases in resolving molecular diagnoses of patients with initially negative genetic testing findings.
UR - https://onlinelibrary.wiley.com/doi/10.1111/cge.14081
UR - http://www.scopus.com/inward/record.url?scp=85118477388&partnerID=8YFLogxK
U2 - 10.1111/cge.14081
DO - 10.1111/cge.14081
M3 - Article
C2 - 34708404
SN - 0009-9163
VL - 101
SP - 247
EP - 254
JO - Clinical Genetics
JF - Clinical Genetics
IS - 2
ER -